Suppr超能文献

中风后遗症功能恢复疗法的发展:迈向无中风后遗症的未来。

Development of Functional Recovery Therapy for Post-Stroke Sequelae: Towards a Future without Stroke Aftereffects.

作者信息

Miyamoto Nobukazu, Hattori Nobutaka

出版信息

Juntendo Med J. 2025 Jan 17;71(1):26-31. doi: 10.14789/ejmj.JMJ24-0026-P. eCollection 2025.

Abstract

Stroke remains a leading cause of mortality and morbidity globally, posing significant challenges to healthcare systems due to its impact on Activities of Daily Living, Quality of Life, and healthcare costs. Current treatments primarily focus on acute management through thrombolytic therapy and thrombectomy, but only a limited number of patients benefit, underscoring the need for effective therapies to aid chronic stroke recovery. Despite ongoing clinical trials, cell therapy faces substantial logistical and cost-related hurdles, limiting its widespread adoption. Strategies to minimalize post-stroke sequelae emphasize preventing cerebral infarction deterioration, utilizing predictive scoring systems for focused treatment, and exploring drug repositioning. The complex interplay within the Neurovascular Unit and Oligovascular Niche highlights the role of various cell types and neurotrophic factors in stroke pathophysiology and recovery phases. Notably, microglia and astrocytes exhibit dual phenotypes ─ either inflammatory or protective ─ depending on the environment, influencing neural damage or repair processes post-stroke. Mitochondrial therapy emerges as a promising avenue, leveraging the organelles' ability to migrate between cells and mitigate inflammatory responses. Studies suggest that mitochondria transferred from astrocytes or other sources could transform inflammatory astrocytes into protective ones, thereby promoting white matter integrity and potentially reducing dementia progression associated with stroke sequelae. In conclusion, addressing stroke's multifaceted challenges requires innovative therapeutic approaches targeting inflammatory mechanisms and enhancing neuroprotection. Early detection and intervention, coupled with advancements in mitochondrial therapy and understanding intercellular interactions, hold promise for improving stroke outcomes and reducing long-term neurological complications.

摘要

中风仍然是全球死亡率和发病率的主要原因,由于其对日常生活活动、生活质量和医疗成本的影响,给医疗系统带来了重大挑战。目前的治疗主要集中在通过溶栓治疗和血栓切除术进行急性管理,但只有少数患者受益,这凸显了需要有效的疗法来帮助慢性中风恢复。尽管正在进行临床试验,但细胞疗法面临着巨大的后勤和成本相关障碍,限制了其广泛应用。将中风后遗症最小化的策略强调预防脑梗死恶化、利用预测评分系统进行针对性治疗以及探索药物重新定位。神经血管单元和少血管微环境内的复杂相互作用突出了各种细胞类型和神经营养因子在中风病理生理学和恢复阶段的作用。值得注意的是,小胶质细胞和星形胶质细胞表现出双重表型——炎症性或保护性——这取决于环境,影响中风后的神经损伤或修复过程。线粒体疗法成为一条有前景的途径,利用细胞器在细胞间迁移和减轻炎症反应的能力。研究表明,从星形胶质细胞或其他来源转移的线粒体可以将炎症性星形胶质细胞转化为保护性星形胶质细胞,从而促进白质完整性,并可能减少与中风后遗症相关的痴呆进展。总之,应对中风的多方面挑战需要针对炎症机制和增强神经保护的创新治疗方法。早期检测和干预,再加上线粒体疗法的进展以及对细胞间相互作用的理解,有望改善中风结果并减少长期神经并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a352/11915467/0802ca3560a3/2759-7504-71-1-0026-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验